Related Experiment Video
Updated: Nov 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Qutuba G Karwi1, Kim L Ho1, Simran Pherwani1
1Department of Pediatrics, Cardiovascular Research Centre, University of Alberta, 423 Heritage Medical Research Centre, Edmonton, Alberta T6G 2S2, Canada.
Insights
Diabetes significantly increases heart failure risk, leading to diabetic cardiomyopathy. Understanding its mechanisms beyond high blood sugar is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus is a major risk factor for heart failure.
- The combination of diabetes and heart failure leads to poorer cardiovascular outcomes.
- Hyperglycemia management alone is insufficient to prevent diabetes-induced heart failure.
Purpose of the Study:
- To summarize diabetic cardiomyopathy characteristics.
- To elucidate the underlying mechanisms of diabetic cardiomyopathy.
- To review therapeutic impacts on diabetes and heart failure.
Main Methods:
- Literature review of diabetic cardiomyopathy.
- Analysis of mechanisms including insulin resistance, fuel preference, oxidative stress, inflammation, cell death, and metabolic dysfunctions.
- Examination of antihyperglycemic and heart failure therapies.
Main Results:
- Diabetic cardiomyopathy involves complex cardiac alterations.
- Mechanisms include insulin resistance, lipotoxicity, glucotoxicity, oxidative stress, inflammation, and altered fuel metabolism.
- Therapeutic strategies for both conditions have overlapping effects.
Conclusions:
- Diabetic cardiomyopathy arises from multiple factors beyond hyperglycemia.
- Further research is needed to fully understand diabetes-induced heart failure.
- Integrated therapeutic approaches are essential for managing co-existing diabetes and heart failure.
Abstract:
Diabetes mellitus increases the risk of developing heart failure, and the co-existence of both diseases worsens cardiovascular outcomes, hospitalization, and the progression of heart failure. Despite current advancements on therapeutic strategies to manage hyperglycaemia, the likelihood of developing diabetes-induced heart failure is still significant, especially with the accelerating global prevalence of diabetes and an ageing population. This raises the likelihood of other contributing mechanisms beyond hyperglycaemia in predisposing diabetic patients to cardiovascular disease risk. There has been considerable interest in understanding the alterations in cardiac structure and function in diabetic patients, collectively termed as 'diabetic cardiomyopathy'. However, the factors that contribute to the development of diabetic cardiomyopathies are not fully understood. This review summarizes the main characteristics of diabetic cardiomyopathies, and the basic mechanisms that contribute to its occurrence. This includes perturbations in insulin resistance, fuel preference, reactive oxygen species generation, inflammation, cell death pathways, neurohormonal mechanisms, advanced glycated end-products accumulation, lipotoxicity, glucotoxicity, and post-translational modifications in the heart of the diabetic. This review also discusses the impact of antihyperglycaemic therapies on the development of heart failure, as well as how current heart failure therapies influence glycaemic control in diabetic patients. We also highlight the current knowledge gaps in understanding how diabetes induces heart failure.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
